Rice Hall James & Associates’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-442,634
Closed -$17.9M 305
2016
Q1
$17.9M Sell
442,634
-929
-0.2% -$34.6K 1.03% 31
2015
Q4
$16M Sell
443,563
-6,108
-1% -$221K 0.91% 44
2015
Q3
$14.4M Buy
449,671
+455
+0.1% +$15.5K 0.93% 42
2015
Q2
$15.3M Buy
449,216
+2,738
+0.6% +$92.2K 0.88% 45
2015
Q1
$15.1M Sell
446,478
-8,042
-2% -$280K 0.87% 41
2014
Q4
$16M Sell
454,520
-11,396
-2% -$384K 0.97% 38
2014
Q3
$15.3M Sell
465,916
-4,446
-0.9% -$151K 1.06% 39
2014
Q2
$16M Buy
470,362
+61,177
+15% +$2.1M 1.08% 37
2014
Q1
$14.3M Sell
409,185
-18,724
-4% -$661K 1.05% 33
2013
Q4
$15.6M Buy
427,909
+95,742
+29% +$3.51M 1.13% 30
2013
Q3
$11.5M Sell
332,167
-29,381
-8% -$1.03M 1.1% 29
2013
Q2
$12.2M Buy
+361,548
New +$12M 1.21% 25

Other funds holding ACH

Rice Hall James & Associates's ACH Position: Q2 2016 in Review

Rice Hall James & Associates sold out of Accendra Health (ACH) in Q2 2016, closing a stake of 442,634 shares — an estimated $17.9M sold.

Rice Hall James & Associates first reported a position in ACH in Q2 2013 and held it in 12 quarters. The position peaked at $17.9M in Q1 2016. 283 funds tracked by Wall St. Rank hold ACH as of Q2 2016.

  • Rice Hall James & Associates reported no remaining Accendra Health position as of Q2 2016 after selling out during the quarter.
  • Rice Hall James & Associates sold 442,634 Accendra Health shares in Q2 2016, an estimated $17.9M.
  • Rice Hall James & Associates first reported a position in Accendra Health in Q2 2013 and held it in 12 quarters.
  • Rice Hall James & Associates's Accendra Health position peaked at $17.9M in Q1 2016.
  • 283 funds tracked by Wall St. Rank held Accendra Health as of Q2 2016.

Based on Rice Hall James & Associates's 13F filing for Q2 2016, filed 27 Jul 2016.